Tribio Anti-LAG-3 & PD-1 Bispecific Antibody (TBS10504)

Description

Description: Trbio Anti-LAG-3 & PD-1 Bispecific Antibody targets LAG-3 and PD-1 to block two inhibitory immune checkpoint pathways and enhance T-cell activation and anti-tumor immune responses. It is mainly used in preclinical cancer immunotherapy studies and murine or in vitro tumor models to evaluate dual checkpoint blockade strategies.

Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Species reactivity: Human

Host species: Human

Target: Lymphocyte activation gene 3 protein, LAG-3, CD223, Secreted lymphocyte activation gene 3 protein, sLAG-3, LAG3, Programmed cell death protein 1, Protein PD-1, hPD-1, CD279, PDCD1

Isotype: Fab-IgG

Accession/UniProt: P18627 & Q15116

Concentration: 3 mg/ml

Purity: >95%

Formulation: Liquid

Storage buffer: 0.01M PBS, pH 7.4

Purification: Protein A/G purified from cell culture supernatant.

Clonality: Monoclonal

Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.

Research use only.

Additional information